PE20120732A1 - Agonistas del receptor de esfingosina-1-fosfato - Google Patents
Agonistas del receptor de esfingosina-1-fosfatoInfo
- Publication number
- PE20120732A1 PE20120732A1 PE2012000174A PE2012000174A PE20120732A1 PE 20120732 A1 PE20120732 A1 PE 20120732A1 PE 2012000174 A PE2012000174 A PE 2012000174A PE 2012000174 A PE2012000174 A PE 2012000174A PE 20120732 A1 PE20120732 A1 PE 20120732A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- alkyl
- oxadiazol
- sphingosine
- crdrd
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE REFIERE A COMPUESTOS HETEROCICLICOS DE FORMULA (I) DONDE R1 ES -(CRdRd)aOH, -(CRdRd)aCOOH, ENTRE OTROS, EN DONDE Rd ES H, OH, ALQUILO(C1-C4), ALCOXI(C1-C4), ENTRE OTROS; a ES DE 0 A 3; R2 ES HALO, -OH, ALQUILO(C1-C4), ENTRE OTROS; R3 Y R4 SON CADA UNO H, ALQUILO(C1-C6) O JUNTO AL ATOMO DE C AL QUE ESTAN UNIDOS FORMAN UN ANILLO DE 3 A 6 MIEMBROS; R5 ES H O ALQUILO(C1-C4); R6 ES ALQUILO(C1-C3), HALO, HALOALQUILO(C1-C3), ENTRE OTROS; m Y n SON CADA UNO 1 O 2; x ES DE 0 A 2; t ES DE 0 A 4; W ES O, CH2 O NH; A ES UN COMPUESTO DE FORMULA (i), (ii), (iii) O (iv), EN DONDE Q ES HETEROARILO MONOCICLICO DE 5 MIEMBROS. SON COMPUESTOS PREFERIDOS: ACIDO 1-(2-HIDROXI-2-(4-(5-(5-FENIL-4-PROPILISOXAZOL-3-IL)-1,2,4-OXADIAZOL-3-IL)FENIL)ETIL)ACETIDINA-3-CARBOXILICO; ACIDO (S)-1-((R)-2-HIDROXI-2-(4-(5-(3-FENIL-4-(TRIFLUOROMETIL)ISOXAZOL-5-IL)-1,2,4-OXADIAZOL-3-IL)FENIL)ETIL)PIPERIDINA-3-CARBOXILICO; 2-(3-(HIDROXIMETIL)PIPERIDIN-1-IL)-1-(4-(5-(3-FENIL-4-(TRIFLUOROMETIL)ISOXAZOL-5-IL)-1,2,4-OXADIAZOL-3-IL)FENIL)ETANOL; ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON AGONISTAS DEL RECEPTOR DE ESFINGOSINA-1-FOSFATO (S1P1) SIENDO UTILES EN EL TRATAMIENTO DE LUPUS ERITEMATOSO SISTEMICO, ARTRITIS REUMATOIDE, ESCLEROSIS MULTIPLE
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23205409P | 2009-08-07 | 2009-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20120732A1 true PE20120732A1 (es) | 2012-06-20 |
Family
ID=43029859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012000174A PE20120732A1 (es) | 2009-08-07 | 2010-08-06 | Agonistas del receptor de esfingosina-1-fosfato |
Country Status (19)
Country | Link |
---|---|
US (1) | US8399451B2 (es) |
EP (1) | EP2462139B1 (es) |
JP (1) | JP5602230B2 (es) |
KR (1) | KR20120108963A (es) |
CN (1) | CN102548989A (es) |
AR (1) | AR077819A1 (es) |
AU (1) | AU2010279354A1 (es) |
BR (1) | BR112012002824A2 (es) |
CA (1) | CA2770194A1 (es) |
CL (1) | CL2012000326A1 (es) |
CO (1) | CO6430439A2 (es) |
EA (1) | EA201270266A1 (es) |
ES (1) | ES2533095T3 (es) |
MX (1) | MX2012001160A (es) |
PE (1) | PE20120732A1 (es) |
SG (1) | SG177691A1 (es) |
TW (1) | TW201109323A (es) |
WO (1) | WO2011017578A1 (es) |
ZA (1) | ZA201200641B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010507619A (ja) * | 2006-10-25 | 2010-03-11 | ノイロサーチ アクティーゼルスカブ | オキサジアゾール及びチアジアゾール化合物並びにニコチン性アセチルコリン受容体調節物質としてのその使用 |
CN103119038B (zh) * | 2010-04-23 | 2016-05-04 | 百时美施贵宝公司 | 作为1-磷酸鞘氨醇1受体激动剂的4-(5-异噁唑基或5-吡唑基-1,2,4-噁二唑基-3-基)扁桃酰胺 |
ES2539256T3 (es) | 2010-07-20 | 2015-06-29 | Bristol-Myers Squibb Company | Compuestos de 3-fenil-1,2,4-oxadiazol sustituidos |
WO2012040532A1 (en) | 2010-09-24 | 2012-03-29 | Bristol-Myers Squibb Company | Substituted oxadiazole compounds and their use as s1p1 agonists |
US8629282B2 (en) | 2010-11-03 | 2014-01-14 | Bristol-Myers Squibb Company | Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases |
UY35338A (es) | 2013-02-21 | 2014-08-29 | Bristol Myers Squibb Company Una Corporación Del Estado De Delaware | Compuestos bicíclicos moduladores de la actividad de s1p1 y composiciones farmacéuticas que los contienen |
UY36274A (es) | 2014-08-20 | 2016-02-29 | Bristol Myers Squibb Company Una Corporación Del Estado De Delaware | Compuestos bicíclicos sustituidos como agonistas selectivos de la actividad del receptor s1p1 acoplado a la proteína g |
TW202023386A (zh) * | 2018-09-13 | 2020-07-01 | 瑞士商先正達合夥公司 | 殺有害生物活性唑-醯胺化合物 |
CN114181276A (zh) * | 2021-12-17 | 2022-03-15 | 安徽大学 | 硫酯肽合成方法 |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4200750A (en) | 1977-01-07 | 1980-04-29 | Westwood Pharmaceuticals Inc. | 4-Substituted imidazo [1,2-a]quinoxalines |
JPS6480026A (en) | 1987-09-21 | 1989-03-24 | Mitsubishi Electric Corp | Resist coater |
DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
TW432061B (en) | 1994-08-09 | 2001-05-01 | Pfizer Res & Dev | Lactams |
US6069143A (en) * | 1994-12-20 | 2000-05-30 | Smithkline Beecham Corporation | Fibrinogen receptor antagonists |
JP2000516234A (ja) | 1996-08-16 | 2000-12-05 | デュポン ファーマシューティカルズ カンパニー | アミジノフェニル―ピロリジン類、アミジノフェニル―ピロリン類、およびアミジノフェニル―イソオキサゾリジン類およびそれらの誘導体 |
EP1575964B1 (en) * | 2002-01-18 | 2009-11-11 | Merck & Co., Inc. | N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
WO2003062252A1 (en) * | 2002-01-18 | 2003-07-31 | Merck & Co., Inc. | Edg receptor agonists |
AU2003216054B2 (en) | 2002-01-18 | 2007-01-04 | Merck & Co., Inc. | Selective S1P1/Edg1 receptor agonists |
US7309721B2 (en) * | 2002-03-01 | 2007-12-18 | Merck + Co., Inc. | Aminoalkylphosphonates and related compounds as Edg receptor agonists |
GEP20074148B (en) * | 2002-04-23 | 2007-07-10 | Bristol Myers Squibb Co | Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
JP2005533058A (ja) * | 2002-06-17 | 2005-11-04 | メルク エンド カムパニー インコーポレーテッド | Edg受容体アゴニストとしての1−((5−アリール−1,2,4−オキサジアゾール−3−イル)ベンジル)アゼチジン−3−カルボキシラートおよび1−((5−アリール−1,2,4−オキサジアゾール−3−イル)ベンジル)ピロリジン−3−カルボキシラート |
WO2004035538A1 (en) | 2002-10-15 | 2004-04-29 | Merck & Co., Inc. | Process for making azetidine-3-carboxylic acid |
JP4516430B2 (ja) | 2002-12-20 | 2010-08-04 | メルク・シャープ・エンド・ドーム・コーポレイション | 1−(アミノ)インダン並びに(1,2−ジヒドロ−3−アミノ)−ベンゾフラン、ベンゾチオフェン及びインドール |
EP1594508B1 (en) | 2003-02-11 | 2012-08-08 | Irm Llc | Novel bicyclic compounds and compositions |
WO2004103279A2 (en) | 2003-05-15 | 2004-12-02 | Merck & Co., Inc. | 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists |
MXPA05012461A (es) | 2003-05-19 | 2006-02-22 | Irm Llc | Compuestos y composiciones inmunosupresores. |
MY150088A (en) | 2003-05-19 | 2013-11-29 | Irm Llc | Immunosuppressant compounds and compositions |
US7060697B2 (en) | 2003-05-19 | 2006-06-13 | Irm Llc | Immunosuppressant compounds and compositions |
BRPI0410746A (pt) | 2003-05-19 | 2006-06-27 | Irm Llc | compostos e composições imunossupressoras |
US20070043014A1 (en) | 2003-10-01 | 2007-02-22 | Merck & Co., Inc. | 3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |
WO2005058848A1 (en) | 2003-12-17 | 2005-06-30 | Merck & Co., Inc. | (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
TW200538433A (en) | 2004-02-24 | 2005-12-01 | Irm Llc | Immunosuppressant compounds and compositiions |
JP2008517915A (ja) | 2004-10-22 | 2008-05-29 | メルク エンド カムパニー インコーポレーテッド | S1p受容体アゴニストとしての2−(アリール)アザシクリルメチルカルボキシレート、スルホネート、ホスホネート、ホスフィネート及びヘテロ環 |
JP2008530135A (ja) | 2005-02-14 | 2008-08-07 | ユニバーシティ オブ バージニア パテント ファンデーション | アミノ基およびフェニル基で置換されたシクロアルカンならびに5員の複素環を含むスフィンゴシン=1−リン酸アゴニスト |
PT1863787E (pt) | 2005-03-23 | 2011-07-29 | Actelion Pharmaceuticals Ltd | Derivados de benzo(c)tiofenos hidrogenados como imunomoduladores |
MX2007011672A (es) | 2005-03-23 | 2007-11-15 | Actelion Pharmaceuticals Ltd | Nuevos derivados de tiofeno como agonistas del receptor de esfingosina-1-fosfato-1. |
CA2605594A1 (en) | 2005-04-22 | 2006-11-02 | Daiichi Sankyo Company, Limited | Heterocyclic compound |
US20080306124A1 (en) | 2005-06-08 | 2008-12-11 | Rainer Albert | Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands |
RU2008101805A (ru) | 2005-06-24 | 2009-07-27 | Актелион Фармасьютиклз Лтд (Ch) | Новые производные тиофена |
BRPI0615133A2 (pt) | 2005-08-23 | 2011-05-03 | Irm Llc | compostos imunossupressores, composições farmacêuticas contendo os mesmos assim como referido uso |
TW200800911A (en) | 2005-10-20 | 2008-01-01 | Biolipox Ab | Pyrazoles useful in the treatment of inflammation |
EP1965807A4 (en) * | 2005-11-23 | 2010-10-27 | Epix Delaware Inc | S1P RECEPTOR MODULATING COMPOUNDS AND THEIR USE |
TWI404706B (zh) | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
GB0601744D0 (en) | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
TW200806611A (en) | 2006-02-09 | 2008-02-01 | Daiichi Seiyaku Co | Novel amidopropionic acid derivatives and medicine containing the same |
AU2007227274A1 (en) * | 2006-03-21 | 2007-09-27 | Epix Delaware, Inc. | S1P receptor modulating compounds |
CA2648303C (en) | 2006-04-03 | 2014-07-15 | Astellas Pharma Inc. | 5-[monocyclic(hetero)arylsubstituted-1,2,4-oxadliazol-3-yl]-(fused heteroaryl substituted) compounds and their use as s1p1 agonists |
US20080070866A1 (en) | 2006-08-01 | 2008-03-20 | Praecis Pharmaceuticals Incorporated | Chemical compounds |
JP2009269819A (ja) | 2006-08-25 | 2009-11-19 | Asahi Kasei Pharma Kk | アミン化合物 |
CA2662852A1 (en) | 2006-09-07 | 2008-03-13 | Allergan, Inc. | Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
TWI408139B (zh) | 2006-09-07 | 2013-09-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
AU2007292993B2 (en) | 2006-09-07 | 2013-01-24 | Idorsia Pharmaceuticals Ltd | Pyridin-4-yl derivatives as immunomodulating agents |
AU2007292992B2 (en) * | 2006-09-08 | 2013-01-10 | Actelion Pharmaceuticals Ltd | Pyridin-3-yl derivatives as immunomodulating agents |
EP2081888A1 (en) | 2006-09-08 | 2009-07-29 | Novartis AG | N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
AU2007298593A1 (en) | 2006-09-21 | 2008-03-27 | Actelion Pharmaceuticals Ltd | Phenyl derivatives and their use as immunomodulators |
AU2007302262A1 (en) | 2006-09-29 | 2008-04-03 | Novartis Ag | Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties |
EP2097397A1 (en) | 2006-11-21 | 2009-09-09 | University Of Virginia Patent Foundation | Tetralin analogs having sphingosine 1-phosphate agonist activity |
AU2007334436A1 (en) | 2006-12-15 | 2008-06-26 | Abbott Laboratories | Novel oxadiazole compounds |
GB0625648D0 (en) | 2006-12-21 | 2007-01-31 | Glaxo Group Ltd | Compounds |
JO2701B1 (en) | 2006-12-21 | 2013-03-03 | جلاكسو جروب ليميتد | Vehicles |
MX2009006751A (es) | 2006-12-21 | 2009-06-30 | Abbott Lab | Compuestos agonistas y antagonistas del receptor de esfingosina-1-fosfato. |
WO2008091967A1 (en) | 2007-01-26 | 2008-07-31 | Smithkline Beecham Corporation | Chemical compounds |
MX2009009597A (es) | 2007-03-16 | 2009-09-16 | Actelion Pharmaceuticals Ltd | Derivados de amino-piridina como agonistas del receptor s1p1/edg1. |
MX2009011155A (es) * | 2007-04-19 | 2009-10-30 | Glaxo Group Ltd | Derivados de indazol oxadiazol sustituidos para su uso como agonistas de esfingosina-1-fosfato (s1p). |
US20090069288A1 (en) | 2007-07-16 | 2009-03-12 | Breinlinger Eric C | Novel therapeutic compounds |
US8202865B2 (en) | 2007-10-04 | 2012-06-19 | Merck Serono Sa | Oxadiazole derivatives |
EP2193126B1 (en) | 2007-10-04 | 2015-06-24 | Merck Serono S.A. | Oxadiazole diaryl compounds |
BRPI0818804A2 (pt) | 2007-11-01 | 2015-04-22 | Actelion Pharmaceuticals Ltd | Composto derivado de pirimidina, composição farmacêutica que o compreende e uso desse composto. |
WO2009080663A1 (en) | 2007-12-21 | 2009-07-02 | Merck Serono S.A. | Triazole oxadiazoles derivatives |
HUE025984T2 (hu) | 2008-05-14 | 2016-05-30 | Scripps Research Inst | Szfingozin foszfát receptor új modulátorai |
JP5537433B2 (ja) | 2008-10-06 | 2014-07-02 | 昭和電工株式会社 | 触媒およびその製造方法ならびにその用途 |
US20100160369A1 (en) * | 2008-12-04 | 2010-06-24 | Exelixis, Inc. | S1P1 Agonists and Methods of Making And Using |
PL2354134T3 (pl) | 2008-12-05 | 2016-07-29 | Astellas Pharma Inc | Pochodne 2h-chromenowe jako stymulatory receptora 1-fosforanu sfingozyny |
BRPI0923178A2 (pt) | 2008-12-18 | 2016-02-16 | Merck Serono Sa | derivados heterocíclicos de oxadiazol fundidos úteis para o tratamento de esclerose múltipla |
AR075319A1 (es) | 2008-12-23 | 2011-03-23 | Novartis Ag | Compuestos de biaril- bencil-amina, procesos para su produccion, su uso como productos farmaceuticos, y composiciones farmaceuticas que los comprenden |
EP2202232A1 (en) | 2008-12-26 | 2010-06-30 | Laboratorios Almirall, S.A. | 1,2,4-oxadiazole derivatives and their therapeutic use |
EP2210890A1 (en) | 2009-01-19 | 2010-07-28 | Almirall, S.A. | Oxadiazole derivatives as S1P1 receptor agonists |
CN102361867A (zh) | 2009-01-23 | 2012-02-22 | 百时美施贵宝公司 | 在治疗自身免疫疾病和炎性疾病中作为s1p激动剂的取代的噁二唑衍生物 |
CN102361868A (zh) | 2009-01-23 | 2012-02-22 | 百时美施贵宝公司 | 作为1-磷酸-鞘氨醇激动剂的吡唑-1,2,4-噁二唑衍生物 |
JP2012515788A (ja) | 2009-01-23 | 2012-07-12 | ブリストル−マイヤーズ スクイブ カンパニー | 自己免疫疾患および炎症性疾患の処置における、s1pアゴニストとしての置換オキサジアゾール誘導体 |
JP5669363B2 (ja) | 2009-03-31 | 2015-02-12 | 昭和電工株式会社 | 樹脂組成物及びこれで処理された紙又は繊維加工品 |
US8724509B2 (en) | 2009-04-03 | 2014-05-13 | Panasonic Corporation | Mobile communication method, mobile communication system, and corresponding apparatus |
-
2010
- 2010-08-05 US US12/850,892 patent/US8399451B2/en active Active
- 2010-08-06 WO PCT/US2010/044627 patent/WO2011017578A1/en active Application Filing
- 2010-08-06 KR KR1020127005901A patent/KR20120108963A/ko not_active Application Discontinuation
- 2010-08-06 CA CA2770194A patent/CA2770194A1/en not_active Abandoned
- 2010-08-06 JP JP2012523967A patent/JP5602230B2/ja not_active Expired - Fee Related
- 2010-08-06 MX MX2012001160A patent/MX2012001160A/es not_active Application Discontinuation
- 2010-08-06 CN CN2010800453726A patent/CN102548989A/zh active Pending
- 2010-08-06 PE PE2012000174A patent/PE20120732A1/es not_active Application Discontinuation
- 2010-08-06 AR ARP100102904A patent/AR077819A1/es not_active Application Discontinuation
- 2010-08-06 EP EP10742067.1A patent/EP2462139B1/en not_active Not-in-force
- 2010-08-06 AU AU2010279354A patent/AU2010279354A1/en not_active Abandoned
- 2010-08-06 TW TW099126390A patent/TW201109323A/zh unknown
- 2010-08-06 SG SG2012003430A patent/SG177691A1/en unknown
- 2010-08-06 ES ES10742067.1T patent/ES2533095T3/es active Active
- 2010-08-06 BR BR112012002824A patent/BR112012002824A2/pt not_active IP Right Cessation
- 2010-08-06 EA EA201270266A patent/EA201270266A1/ru unknown
-
2012
- 2012-01-24 ZA ZA2012/00641A patent/ZA201200641B/en unknown
- 2012-02-07 CL CL2012000326A patent/CL2012000326A1/es unknown
- 2012-02-16 CO CO12027713A patent/CO6430439A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN102548989A (zh) | 2012-07-04 |
JP2013501729A (ja) | 2013-01-17 |
ES2533095T3 (es) | 2015-04-07 |
EP2462139A1 (en) | 2012-06-13 |
TW201109323A (en) | 2011-03-16 |
KR20120108963A (ko) | 2012-10-05 |
WO2011017578A1 (en) | 2011-02-10 |
MX2012001160A (es) | 2012-02-13 |
US8399451B2 (en) | 2013-03-19 |
EP2462139B1 (en) | 2015-01-14 |
AU2010279354A1 (en) | 2012-02-09 |
SG177691A1 (en) | 2012-02-28 |
CO6430439A2 (es) | 2012-04-30 |
EA201270266A1 (ru) | 2012-07-30 |
AR077819A1 (es) | 2011-09-28 |
JP5602230B2 (ja) | 2014-10-08 |
US20110190255A1 (en) | 2011-08-04 |
CL2012000326A1 (es) | 2012-10-19 |
ZA201200641B (en) | 2013-06-26 |
CA2770194A1 (en) | 2011-02-10 |
BR112012002824A2 (pt) | 2019-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20120732A1 (es) | Agonistas del receptor de esfingosina-1-fosfato | |
PE20081398A1 (es) | Derivados de oxadiazol como agonistas del receptor sensible a 1-fosfato de esfingosina (s1p1) | |
WO2009051956A3 (en) | Pyrazole-substituted isoxazoline insecticides | |
PE20140207A1 (es) | Composiciones y metodos para modular el fxr | |
RU2009139920A (ru) | Изоксазолиновые соединения и их применение в борьбе с вредителями | |
PE20061038A1 (es) | Derivados del 1,5-difenil-1h-pirazol-3-il) oxadiazol como agentes antagonistas cb1 y su preparacion | |
PE20090992A1 (es) | Derivados de fenil-amino-pirimidina como agentes inhibidores de cinasa | |
EA201101089A1 (ru) | Производные оксадиазола в качестве агонистов рецептора s1p1 | |
EA201170096A1 (ru) | Замещенные производные пиримидона | |
CO6220851A2 (es) | Compuestos de ciclohexandiona sustituidos en la posicion 5 | |
PE20081199A1 (es) | Derivados de azacicloalcanos como inhibidores de estearoil-coenzima a delta-9 desaturasa | |
JP2010504286A5 (es) | ||
PE20120656A1 (es) | 2-acetamido-5-aril-1, 2, 4-triazolonas sustituidas y su uso | |
TW200732329A (en) | Aryl-isoxazolo-4-yl-oxadiazole derivatives | |
PE20080360A1 (es) | Derivados 4-bencilftalazinona 2-sustituidos como antagonistas de histaminas h1 y h3 | |
PE20120690A1 (es) | Derivados de 5-fluoropirimidinona | |
RU2008112691A (ru) | Азотсодержащее гетероциклическое соединение и его фармацевтическое применение | |
PE20140868A1 (es) | Antagonistas trpm8 y su uso en tratamientos | |
PE20090477A1 (es) | Derivados de oxazol como inhibidores de los canales de sodio | |
PE20120657A1 (es) | Compuesto para el tratamiento de trastornos metabolicos | |
PE20070460A1 (es) | Derivados de carboxamida como antagonista del receptor muscarinico | |
PE20120362A1 (es) | Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapia | |
MX338631B (es) | 5-(fenil/piridinil-etinil)-2-piridina/ 2-pirimidina-carboxamidas como moduladores del receptor de glutamato metabotropico del subtipo 5 (mglur5). | |
IN2012DN00770A (es) | ||
PE20120934A1 (es) | Piperidinas sustituidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |